An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril

Magdalena I Ivanova1, Michael R Sawaya, Mari Gingery

  • 1Howard Hughes Medical Institute and University of California-Department of Energy Institute of Genomics and Proteomics, Box 951570, University of California, Los Angeles, CA 90095, USA.

Insights

A specific seven-residue peptide in human beta2-microglobulin (beta2M) drives amyloid formation. This finding is crucial for understanding dialysis-related amyloidosis and beta2M

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medical Research

Background:

  • Dialysis-related amyloidosis in humans involves beta2-microglobulin (beta2M) amyloid deposition.
  • Beta2M amyloid is not observed in mice, despite high sequence homology with human beta2M.

Purpose of the Study:

  • To identify the specific regions of beta2M responsible for amyloid formation.
  • To elucidate the molecular mechanisms underlying beta2M amyloidogenesis.

Main Methods:

  • Comparative sequence analysis of human and mouse beta2M.
  • In vitro amyloid formation assays using synthetic peptides.
  • Site-directed mutagenesis to substitute human and mouse peptide segments.

Main Results:

  • A seven-residue peptide segment in human beta2M, differing significantly from its mouse counterpart, was identified.
  • This human peptide segment readily formed amyloid in vitro, while the mouse segment did not.
  • Replacing the mouse segment with the human segment in mouse beta2M induced in vitro amyloid formation.

Conclusions:

  • A specific seven-residue segment of human beta2M is sufficient to induce amyloid formation.
  • Key residue differences within this segment are critical for beta2M conversion to the amyloid state.
  • These findings support the Zipper-spine model for beta2M amyloid structure.

Related Concept Videos

Protein Organization01:13

Protein Organization

Overview
Protein Folding01:22

Protein Folding

Overview
Protein and Protein Structure02:15

Protein and Protein Structure

Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme can...
Globular and Fibrous Proteins02:21

Globular and Fibrous Proteins

Many proteins can be classified into two distinct subtypes - globular or fibrous. These two types differ in their shapes and solubilities.
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...